SNY Sanofi
Healthcare$44.29-1.40%ClosedMarket Cap: $106.67B
As of 2026-05-25
Valuation
P/E (TTM)
14.60
PEG
0.36
P/B
1.28
P/S
1.58
EV/EBITDA
9.87
DCF Value
$141.83
FCF Yield
20.3%
Div Yield
5.3%
Margins & Returns
Gross Margin
71.6%
Operating Margin
25.1%
Net Margin
17.6%
ROE
14.4%
ROA
8.1%
ROIC
11.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $11.24B | 72.1% | $2.27B | $1.61B | $— | — |
| Q4 null | $12.21B | 70.3% | $-1.04B | $-801.0M | $— | — |
| FY null | $46.72B | 72.1% | $9.60B | $7.81B | $— | $2.21 |
| Q3 null | $13.17B | 74.1% | $3.62B | $2.80B | $— | — |
| Q2 null | $10.73B | 72.1% | $1.47B | $3.94B | $— | $2.21 |
| Q1 null | $10.61B | 72.8% | $2.23B | $1.87B | $— | — |
| Q4 null | $7.63B | 70.2% | $573.0M | $499.0M | $— | — |
| FY null | $44.29B | 70.2% | $7.25B | $5.56B | $— | $2.04 |
| Q3 null | $14.16B | 71.1% | $3.63B | $2.81B | $— | — |
| Q2 null | $11.38B | 70.0% | $1.59B | $1.11B | $— | $2.04 |
| Q1 null | $9.73B | 69.5% | $1.24B | $1.13B | $— | — |
| Q4 2023 | $12.20B | 66.8% | $342.0M | $-555.0M | $-0.22 | — |